NEW

Philips Partners with DiA Imaging Analysis

Royal Philips and DiA Imaging Analysis Ltd., a provider of AI-powered applications for ultrasound, have announced a strategic partnership* to deliver automated solutions to clinicians at the point-of-care.

Philips spotlights new solutions at ECR 2021

Royal Philips has announced its participation in the European Congress of Radiology (ECR) virtual event, March 3-7, 2021, where the company will feature new and enhanced diagnostic and interventional solutions that further expand its Radiology Workflow Suite, connecting data, technology and people across the imaging enterprise.

Epsilon Imaging Partners with Siemens Healthineers

Epsilon Imaging, a visualization and analysis software provider transforming cardiac diagnostic workflow with strain imaging, has announced a partnership with Siemens Healthineers, a leading developer of medical imaging and information management solutions, to offer syngo Dynamics users EchoInsight visualization and analysis with strain imaging.

iRad Announces a Distributorship Agreement with FUJIFILM Medical Systems

iRad, Innovative Radiology Equipment Sales and Services, LLC has announced a distributorship agreement with FUJIFILM Medical Services.

KUBTEC Granted Additional Patent

KUBTEC has announced that the U.S. Patent Office has granted the company an additional patent for its technology used for breast specimen imaging using 3-D tomosynthesis.

The patent, Specimen Radiography with Tomosynthesis in a Cabinet (Patent Number 9,642,581 B2) was issued on May 9, 2017 and refers to technology currently embodied in the KUBTEC Mozart System, the only intraoperative specimen imaging system to use 3-D Tomosynthesis to give breast surgeons a superior view of their surgical margins. A recent study has demonstrated that the use of this technology enables significant reductions in surgical re-excision rates when compared to the more traditional 2-D planar imaging.

“This patent is recognition that our continued investment in new technology specifically for breast cancer specimen imaging is resulting in new products that really make a difference to people’s live,” KUBTEC CEO Vikram Butani said. “As the health care market shifts its focus to reimbursement based on quality of care and patient satisfaction, we are positioned to provide solutions that impact these metrics by improving surgical accuracy and reducing avoidable re-hospitalizations for breast cancer patients.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *